Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

DH Barouch, JB Whitney, B Moldt, F Klein, TY Oliveira… - Nature, 2013 - nature.com
Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with
extraordinary potency and breadth have recently been described. In humanized mice …

[PDF][PDF] Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys

J Liu, KE Stephenson - Nature, 2013 - core.ac.uk
Abstract HIV-1-specific monoclonal antibodies (mAbs) with extraordinary potency and
breadth have recently been described. In humanized mice, combinations of mAbs have …

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

DH Barouch, JB Whitney, B Moldt, F Klein… - …, 2013 - search.ebscohost.com
Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with
extraordinary potency and breadth have recently been described. In humanized mice …

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

DH Barouch, JB Whitney, B Moldt, F Klein, TY Oliveira… - 2013 - dspace.mit.edu
Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with
extraordinary potency and breadth have recently been described. In humanized mice …

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

DH Barouch, JB Whitney, B Moldt, F Klein, TY Oliveira… - 2013 - cabidigitallibrary.org
Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with
extraordinary potency and breadth have recently been described. In humanized mice …

[PDF][PDF] Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

DH Barouch, JB Whitney, B Moldt, F Klein, TY Oliveira… - 2013 - natap.org
Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with
extraordinary potency and breadth have recently been described. In humanized mice …

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

DH Barouch, JB Whitney, B Moldt, F Klein, TY Oliveira… - Nature, 2013 - europepmc.org
Abstract HIV-1-specific monoclonal antibodies (mAbs) with extraordinary potency and
breadth have recently been described. In humanized mice, combinations of mAbs have …

[引用][C] Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

DH Barouch, JB Whitney, B Moldt, F Klein, TY Oliveira… - Nature, 2013 - cir.nii.ac.jp
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected
rhesus monkeys | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

[PDF][PDF] Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

DH Barouch, JB Whitney, B Moldt, F Klein, TY Oliveira… - NATURE, 2013 - researchgate.net
Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with
extraordinary potency and breadth have recently been described. In humanized mice …

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

DH Barouch, JB Whitney, B Moldt, F Klein… - Nature, 2013 - econpapers.repec.org
Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with
extraordinary potency and breadth have recently been described. In humanized mice …